{
    "organizations": [],
    "uuid": "068df3acb97b7916e61c6cbe2e66f433e1874ead",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-ovid-therapeutics-reports-q1-loss/brief-ovid-therapeutics-reports-q1-loss-per-share-of-0-54-idUSASC0A0OM",
    "ord_in_thread": 0,
    "title": "BRIEF-Ovid Therapeutics Reports Q1 Loss Per Share Of $0.54",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 8 (Reuters) - Ovid Therapeutics Inc:\n* OVID THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND CORPORATE PROGRESS\n* Q1 LOSS PER SHARE $0.54 * Q1 EARNINGS PER SHARE VIEW $-0.52 â€” THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-09T06:51:00.000+03:00",
    "crawled": "2018-05-09T12:20:19.056+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "ovid",
        "therapeutic",
        "inc",
        "ovid",
        "therapeutic",
        "report",
        "first",
        "quarter",
        "financial",
        "result",
        "corporate",
        "progress",
        "q1",
        "loss",
        "per",
        "share",
        "q1",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}